The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma

被引：0
作者：
Kai Rejeski
Doris K. Hansen
Radhika Bansal
Pierre Sesques
Sikander Ailawadhi
Jennifer M. Logue
Eva Bräunlein
David M. Cordas dos Santos
Ciara L. Freeman
Melissa Alsina
Sebastian Theurich
Yucai Wang
Angela M. Krackhardt
Frederick L. Locke
Emmanuel Bachy
Michael D. Jain
Yi Lin
Marion Subklewe
机构：
[1] LMU Munich,Department of Medicine III – Hematology/Oncology, LMU University Hospital
[2] LMU Gene Center,Laboratory for Translational Cancer Immunology
[3] German Cancer Consortium (DKTK),Department of Blood and Marrow Transplant and Cellular Immunotherapy
[4] Munich Site,Division of Hematology
[5] and German Cancer Research Center,Division of Hematology and Oncology
[6] Bavarian Cancer Research Center (BZKF),IIIrd Medical Department, Klinikum rechts der Isar and Center for Translational Cancer Research (TranslaTUM), School of Medicine
[7] Moffitt Cancer Center,Department of Medicine I
[8] Mayo Clinic,undefined
[9] Hospices Civils de Lyon,undefined
[10] Université Claude Bernard Lyon 1,undefined
[11] INSERM 1052,undefined
[12] Mayo Clinic,undefined
[13] Technical University of Munich,undefined
[14] Malteser Hospital St. Franziskus Hospital,undefined
来源：
Journal of Hematology & Oncology | / 16卷
关键词：
Chimeric antigen receptor; BCMA CAR-T; Hematological toxicity; Cytopenias; Multiple myeloma; Infections;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Impact of glucocorticoids on short-term and long-term outcomes in patients with relapsed/refractory multiple myeloma treated with CAR-T therapy
    Wang, Xue
    Qi, Yuekun
    Li, Hujun
    Liu, Fengan
    Cao, Jiang
    Chen, Wei
    Wang, Ying
    Qi, Kunming
    Yan, Zhiling
    Zhu, Feng
    Li, Zhenyu
    Cheng, Hai
    Xu, Kailin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report
    D. Madduri
    S. Parekh
    T. B. Campbell
    F. Neumann
    F. Petrocca
    S. Jagannath
    Journal of Medical Case Reports, 15
  • [43] Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report
    Madduri, D.
    Parekh, S.
    Campbell, T. B.
    Neumann, F.
    Petrocca, F.
    Jagannath, S.
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [44] Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy
    Jagannath, Sundar
    Kharat, Akshay
    Fu, Alex
    Huo, Stephen
    Kohli, Monal
    Adams, Shayna
    Umeh, Emeka
    Foster, Miran
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S511 - S512
  • [45] Pomalidomide improves the effectiveness of CAR-T treatment in the relapsed and refractory multiple myeloma or B-cell leukemia/lymphoma with extramedullary disease
    Zhao, Jie
    Yang, Hui
    Ge, Junnan
    Li, Linyu
    Yao, Qiong
    He, Shaolong
    Zhu, Qiujuan
    Ren, Ruiui
    Li, Chunrui
    Ma, Liangming
    Tian, Weiwei
    Wei, Jia
    BLOOD SCIENCE, 2024, 6 (02): : e00184
  • [46] Therapy related acute myeloid leukemia secondary to CAR-T therapy in refractory/relapsed multiple myeloma patient showing poor prognosis
    An, Ran
    Bao, Weiying
    Yan, Zeying
    Sun, Haimin
    Xu, Xiaoqian
    Zhang, Sujiang
    ANNALS OF HEMATOLOGY, 2025, : 2013 - 2016
  • [47] Effects of Consolidation Therapy With Autologous Hematopoietic Stem Cell Transplantation After BCMA-CAR T-Cell Therapy on the Survival of Patients With Relapsed or Refractory Multiple Myeloma
    Zhou, Ziwei
    Liu, Xuan
    Zhang, Xuejun
    Wen, Shupeng
    Hua, Huan
    Xu, Zheng
    Wang, Fuxu
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (11): : 1080e1 - 1080e11
  • [48] Achieving stringent complete remission in relapsed/refractory multiple myeloma with liver extramedullary disease after CAR-T cell therapy: A case report
    Zhou, Lingyun
    Liu, Danbo
    Du, Fang
    Chen, Jiao
    Lu, Wenyi
    Xiang, Hongxian
    Chen, Haifei
    ONCOLOGY LETTERS, 2025, 29 (05)
  • [49] Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature
    Qian, Ying
    Qian, Zijun
    Zhao, Xiujie
    Pan, Wenjue
    Wei, Xinzheng
    Meng, Huimin
    Yang, Lin
    Xiao, Haowen
    FRONTIERS IN MEDICINE, 2021, 8
  • [50] A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells
    Liu, Yang
    Jie, Xingxing
    Nian, Li
    Wang, Ying
    Wang, Congyue
    Ma, Jin
    Jiang, Jingjing
    Wu, Qingyun
    Qiao, Jianlin
    Chen, Wei
    Cao, Jiang
    Yan, Zhiling
    Shi, Ming
    Cheng, Hai
    Zhu, Feng
    Sang, Wei
    Li, Depeng
    Chen, Chong
    Xu, Kailin
    Li, Zhenyu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345